Boston Scientific Neuromodulation secures three grants for implantable device architecture and stimulation control.
The filing
On November 10, 2026, Boston Scientific Neuromodulation Corporation received three US patents covering implantable device architecture, symptom-responsive stimulation control, and patterned deep brain stimulation programming. The company also saw Nalu Medical, Inc.'s application for enhanced stimulation waveforms published on November 12, 2026. US20260355527A1 (opens in a new tab)
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.